17/03/2026
Huge appreciation for the incredible team of Dr Fleischer representing ACTA2 Alliance at the ACMG Annual Clinical Genetics Meeting in Baltimore 👏
Dr. Julie Fleischer and her dedicated team-Kara Skorge, Samantha Siefken and Abe Fleischer are truly making a difference- showing up for our community and raising awareness. Their work is helping clinicians better recognize ACTA2 MSMDS, understand the complexities and ultimately improve care for our children💜🩵
Last week, the ACTA2 Alliance was present at the Annual Clinical Genetics Meeting in Baltimore, organized by the ACMG - American College of Medical Genetics and Genomics. It was an incredible opportunity to reach around 3,000 genetics providers and speak directly with about 100 of them, raising awareness of ACTA2 & MSMDS.
These conversations matter. They help clinicians recognize the signs earlier, understand surgical risks, and ultimately provide better care for our children.
We’re especially grateful for the incredible team behind this effort:
Kara Skorge, Samantha Siefken, Abe Fleischer and Julie Fleischer, geneticist and member of our Scientific and Medical Advisory Board.
Not only did they educate new providers, but they also connected with clinicians already caring for ACTA2 patients, sharing updated research, resources, and opportunities to collaborate.
Samantha also presented new data on MSMDS patients, with plans to publish soon, another important step forward for our community.
This is what progress looks like: showing up, starting conversations, and making sure ACTA2 mutations and MSMDS are seen, understood, and recognized.
If you’re grateful for their work, let’s fill the comments with 👏👏👏 for this amazing team.